mikeruge logo small whitemikeruge logo small whitemikeruge logo small whitemikeruge logo small white
  • Home
  • Michael Ruge
  • Recommendations
  • Blog
  • Links
Show all

Orgenesis and Remedy Therapeutics in Collaboration to Kind Joint Enterprise Settlement for Cell and Gene Therapies

The collaboration includes the development, commercialization, and supply of Orgenesis’ pipeline in South Korea and Japan and the development and commercialization of Cure Therapeutics’ pipeline on a global basis.

On Dec. 9, 2020, Orgenesis, a global biotech company focused on cell and gene therapies, and Cure Therapeutics, a developer of immuno-oncology and cell and gene therapies, announced that they have signed a joint venture agreement to advance the development, regulatory and governmental approval, and commercialization of point-of-care (POCare) production for both companies’ cell and gene therapies as well as immunotherapies.

Under the agreement, the companies will collaborate to develop and commercialize Cure Therapeutics’ pipeline on a global basis. The companies will also collaborate on the development, commercialization, and supply of Orgenesis’ therapeutic pipeline in South Korea and Japan. According to the terms, Cure Therapeutics and Orgenesis will contribute at least $10 million to the joint venture to cover operating costs, $5 million of which may be provided in the form of in-kind contribution.

The partnership will first focus on aligning the efforts of both companies to advance proprietary Orgenesis chimeric antigen receptor T cell (CAR-T), tumor infiltrating lymphocytes (TILS), and Duvac (cellular vaccine) therapies into clinical trials in South Korea and Japan. Process development and validation will be completed by leveraging the POCare technologies from the Orgenesis platform to achieve automated manufacturing at the point of care.

“This collaboration between Orgenesis and Cure Therapeutics further expands our cell and gene therapy pipeline and provides a clear illustration of the international scope of our POCare Platform,” said Vered Caplan, CEO of Orgenesis, in a company press release. “We selected Cure Therapeutics as our partner in South Korea and Japan given their expertise in the region and robust immunotherapy pipeline. Additionally, this [a]greement supports Orgenesis’ continued efforts to complement the Orgenesis pipeline and distribution efforts in the United States, Europe, and globally.”

“The joint venture and partnership with Orgenesis will provide a significant international route to market for our immunotherapies targeting cancers and infectious diseases. Cure Therapeutics will leverage the Orgenesis POCare Network of leading international healthcare institutions to accelerate the international development and market approvals for our portfolio,” said David Kim, CEO of Cure Therapeutics, in the press release. “In parallel, we will leverage our established network to help develop and rapidly advance the Orgenesis cell and gene therapy portfolio in South Korea and Japan.”

Source: Orgenesis

Share
0
Michael Ruge

Michael Ruge

Related posts

Solomon Credit score Administration and SACH Plan Joint Enterprise to Develop Healthcare and Wellness Manufacturers Throughout Southeast Asia – DagangNews


Read more

Penn Drugs and IBA Launch Joint Enterprise to Advance Proton Remedy and Radiation Oncology Program Growth Worldwide – The Manila Occasions


Read more

How MCT Joint Enterprise Will Influence Rush Enterprises Inventory (RUSH.A) Traders – simplywall.st


Read more

Michael Ruge Duncan BC - Site Map

Michael Ruge | Michael Ruge | Michael Ruge

Tags

Affordable Apartments Affordable Housing Affordable Living All Ways Solutions AllWaysSolutions.com Bank Account Branding Bruce Firestone Building Hope in the Housing Business Business Marketing Canada’s Housing Crisis Consignment Consultant Consultanting Deal Making Entrepreneur File Storage Funding Real Estate Development Funding Real Estate Projects Housing Crisis Joint Venture Joint Venture Account Make a Deal Marketing Market Research Michael E Ruge Michael Ruge Michael Ruge Author Negotiation Negotiations Problem Solving Real Estate Development Real Estate Innovation Record Management Records-Management Records-Management Solutions Record Storage Rent-to-Own Self Storage Sharing Profit Storage Storage File Experts Target Markets Urban Sprawl
© 2026 Michael Ruge. All Rights Reserved
Web Development by JustLuvIt
Michael E Ruge | Michael Ernst Ruge | All Ways Solutions | Ruge Charities